Axa S.A. Age X Therapeutics, Inc. Transaction History

Axa S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 13, 2019	SELL	$2.58 - $4.92 $312,845 - $596,589	-121,258 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$2.49 - $5.5 $301,932 - $666,919	121,258 New	121,258 $363,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.